 | • レポートコード：D0804-10056 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、136ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、植物源抗がん剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。植物源抗がん剤の種類別市場規模（パクリタキセル、ビノレルビン、イリノテカン、ヒドロキシカンプトテシン、ドセタキセル、その他）、用途別市場規模（卵巣がん、子宮頸がん、乳がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Phyton、Huiang biopharma、Samyang、ScinoPharm、Fresenius-kabi、Novasep、Yunnan Hande、TAPI (Teva)、Polymed、Southpharma、Actiza Pharmaceutical、Cipla、Hainan Yew Pharm、Getwell、Pfizer、Jiangsu Yew Biotechnology、Salius、Taj Pharma、West-Ward Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・植物源抗がん剤の北米市場（アメリカ、カナダ、メキシコ） ・植物源抗がん剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・植物源抗がん剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・植物源抗がん剤の南米市場（ブラジル、アルゼンチン） ・植物源抗がん剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：パクリタキセル、ビノレルビン、イリノテカン、ヒドロキシカンプトテシン、ドセタキセル、その他 ・用途別分析：卵巣がん、子宮頸がん、乳がん、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Plant Sources Anti Cancer Agents market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Plant Sources Anti Cancer Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Plant Sources Anti Cancer Agents market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Plant Sources Anti Cancer Agents market has been segmented into
Paclitaxel
Vinorelbine
Irinotecan
Hydroxycamptothecin
Docetaxel
Other
By Application, Plant Sources Anti Cancer Agents has been segmented into:
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Plant Sources Anti Cancer Agents market presented in the report. This section sheds light on the sales growth of different regional and country-level Plant Sources Anti Cancer Agents markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Plant Sources Anti Cancer Agents market.
The report offers in-depth assessment of the growth and other aspects of the Plant Sources Anti Cancer Agents market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Plant Sources Anti Cancer Agents Market Share Analysis
Plant Sources Anti Cancer Agents competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Plant Sources Anti Cancer Agents sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Plant Sources Anti Cancer Agents sales, revenue and market share for each player covered in this report.
The major players covered in Plant Sources Anti Cancer Agents are:
Phyton
Huiang biopharma
Samyang
ScinoPharm
Fresenius-kabi
Novasep
Yunnan Hande
TAPI (Teva)
Polymed
Southpharma
Actiza Pharmaceutical
Cipla
Hainan Yew Pharm
Getwell
Pfizer
Jiangsu Yew Biotechnology
Salius
Taj Pharma
West-Ward Pharmaceuticals
Among other players domestic and global, Plant Sources Anti Cancer Agents market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plant Sources Anti Cancer Agents product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Plant Sources Anti Cancer Agents, with price, sales, revenue and global market share of Plant Sources Anti Cancer Agents in 2018 and 2019.
Chapter 3, the Plant Sources Anti Cancer Agents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plant Sources Anti Cancer Agents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Plant Sources Anti Cancer Agents market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Plant Sources Anti Cancer Agents sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Plant Sources Anti Cancer Agents Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Plant Sources Anti Cancer Agents Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Paclitaxel
1.2.3 Vinorelbine
1.2.4 Irinotecan
1.2.5 Hydroxycamptothecin
1.2.6 Docetaxel
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Plant Sources Anti Cancer Agents Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Other
1.4 Overview of Global Plant Sources Anti Cancer Agents Market
1.4.1 Global Plant Sources Anti Cancer Agents Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Phyton
2.1.1 Phyton Details
2.1.2 Phyton Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Phyton SWOT Analysis
2.1.4 Phyton Product and Services
2.1.5 Phyton Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Huiang biopharma
2.2.1 Huiang biopharma Details
2.2.2 Huiang biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Huiang biopharma SWOT Analysis
2.2.4 Huiang biopharma Product and Services
2.2.5 Huiang biopharma Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Samyang
2.3.1 Samyang Details
2.3.2 Samyang Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Samyang SWOT Analysis
2.3.4 Samyang Product and Services
2.3.5 Samyang Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 ScinoPharm
2.4.1 ScinoPharm Details
2.4.2 ScinoPharm Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 ScinoPharm SWOT Analysis
2.4.4 ScinoPharm Product and Services
2.4.5 ScinoPharm Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Fresenius-kabi
2.5.1 Fresenius-kabi Details
2.5.2 Fresenius-kabi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Fresenius-kabi SWOT Analysis
2.5.4 Fresenius-kabi Product and Services
2.5.5 Fresenius-kabi Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novasep
2.6.1 Novasep Details
2.6.2 Novasep Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novasep SWOT Analysis
2.6.4 Novasep Product and Services
2.6.5 Novasep Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Yunnan Hande
2.7.1 Yunnan Hande Details
2.7.2 Yunnan Hande Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Yunnan Hande SWOT Analysis
2.7.4 Yunnan Hande Product and Services
2.7.5 Yunnan Hande Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 TAPI (Teva)
2.8.1 TAPI (Teva) Details
2.8.2 TAPI (Teva) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 TAPI (Teva) SWOT Analysis
2.8.4 TAPI (Teva) Product and Services
2.8.5 TAPI (Teva) Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Polymed
2.9.1 Polymed Details
2.9.2 Polymed Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Polymed SWOT Analysis
2.9.4 Polymed Product and Services
2.9.5 Polymed Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Southpharma
2.10.1 Southpharma Details
2.10.2 Southpharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Southpharma SWOT Analysis
2.10.4 Southpharma Product and Services
2.10.5 Southpharma Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Actiza Pharmaceutical
2.11.1 Actiza Pharmaceutical Details
2.11.2 Actiza Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Actiza Pharmaceutical SWOT Analysis
2.11.4 Actiza Pharmaceutical Product and Services
2.11.5 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Cipla
2.12.1 Cipla Details
2.12.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Cipla SWOT Analysis
2.12.4 Cipla Product and Services
2.12.5 Cipla Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Hainan Yew Pharm
2.13.1 Hainan Yew Pharm Details
2.13.2 Hainan Yew Pharm Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Hainan Yew Pharm SWOT Analysis
2.13.4 Hainan Yew Pharm Product and Services
2.13.5 Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Getwell
2.14.1 Getwell Details
2.14.2 Getwell Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Getwell SWOT Analysis
2.14.4 Getwell Product and Services
2.14.5 Getwell Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Pfizer
2.15.1 Pfizer Details
2.15.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Pfizer SWOT Analysis
2.15.4 Pfizer Product and Services
2.15.5 Pfizer Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Jiangsu Yew Biotechnology
2.16.1 Jiangsu Yew Biotechnology Details
2.16.2 Jiangsu Yew Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Jiangsu Yew Biotechnology SWOT Analysis
2.16.4 Jiangsu Yew Biotechnology Product and Services
2.16.5 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Salius
2.17.1 Salius Details
2.17.2 Salius Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Salius SWOT Analysis
2.17.4 Salius Product and Services
2.17.5 Salius Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Taj Pharma
2.18.1 Taj Pharma Details
2.18.2 Taj Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Taj Pharma SWOT Analysis
2.18.4 Taj Pharma Product and Services
2.18.5 Taj Pharma Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 West-Ward Pharmaceuticals
2.19.1 West-Ward Pharmaceuticals Details
2.19.2 West-Ward Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 West-Ward Pharmaceuticals SWOT Analysis
2.19.4 West-Ward Pharmaceuticals Product and Services
2.19.5 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Plant Sources Anti Cancer Agents Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Plant Sources Anti Cancer Agents Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Plant Sources Anti Cancer Agents Manufacturer Market Share in 2019
3.3.2 Top 6 Plant Sources Anti Cancer Agents Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Plant Sources Anti Cancer Agents Sales, Revenue and Market Share by Regions
4.1.1 Global Plant Sources Anti Cancer Agents Sales and Market Share by Regions (2015-2020)
4.1.2 Global Plant Sources Anti Cancer Agents Revenue and Market Share by Regions (2015-2020)
4.2 North America Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
4.3 Europe Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
4.5 South America Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Plant Sources Anti Cancer Agents Sales, Revenue and Market Share by Country
5.1.1 North America Plant Sources Anti Cancer Agents Sales and Market Share by Country (2015-2020)
5.1.2 North America Plant Sources Anti Cancer Agents Revenue and Market Share by Country (2015-2020)
5.2 United States Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
5.3 Canada Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
5.4 Mexico Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Plant Sources Anti Cancer Agents Sales, Revenue and Market Share by Country
6.1.1 Europe Plant Sources Anti Cancer Agents Sales and Market Share by Country (2015-2020)
6.1.2 Europe Plant Sources Anti Cancer Agents Revenue and Market Share by Country (2015-2020)
6.2 Germany Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
6.3 UK Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
6.4 France Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
6.5 Russia Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
6.6 Italy Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Plant Sources Anti Cancer Agents Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Plant Sources Anti Cancer Agents Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Plant Sources Anti Cancer Agents Revenue and Market Share by Regions (2015-2020)
7.2 China Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
7.3 Japan Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
7.4 Korea Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
7.5 India Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
7.7 Australia Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Plant Sources Anti Cancer Agents Sales, Revenue and Market Share by Country
8.1.1 South America Plant Sources Anti Cancer Agents Sales and Market Share by Country (2015-2020)
8.1.2 South America Plant Sources Anti Cancer Agents Revenue and Market Share by Country (2015-2020)
8.2 Brazil Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
8.3 Argentina Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Plant Sources Anti Cancer Agents Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Plant Sources Anti Cancer Agents Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Plant Sources Anti Cancer Agents Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
9.3 Turkey Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
9.4 Egypt Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
9.5 South Africa Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Plant Sources Anti Cancer Agents Sales and Market Share by Type (2015-2020)
10.2 Global Plant Sources Anti Cancer Agents Revenue and Market Share by Type (2015-2020)
10.3 Global Plant Sources Anti Cancer Agents Price by Type (2015-2020)
11 Global Plant Sources Anti Cancer Agents Market Segment by Application
11.1 Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2015-2020)
11.2 Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2015-2020)
11.3 Global Plant Sources Anti Cancer Agents Price by Application (2015-2020)
12 Market Forecast
12.1 Global Plant Sources Anti Cancer Agents Sales, Revenue and Growth Rate (2021-2025)
12.2 Plant Sources Anti Cancer Agents Market Forecast by Regions (2021-2025)
12.2.1 North America Plant Sources Anti Cancer Agents Market Forecast (2021-2025)
12.2.2 Europe Plant Sources Anti Cancer Agents Market Forecast (2021-2025)
12.2.3 Asia-Pacific Plant Sources Anti Cancer Agents Market Forecast (2021-2025)
12.2.4 South America Plant Sources Anti Cancer Agents Market Forecast (2021-2025)
12.2.5 Middle East & Africa Plant Sources Anti Cancer Agents Market Forecast (2021-2025)
12.3 Plant Sources Anti Cancer Agents Market Forecast by Type (2021-2025)
12.3.1 Global Plant Sources Anti Cancer Agents Sales Forecast by Type (2021-2025)
12.3.2 Global Plant Sources Anti Cancer Agents Market Share Forecast by Type (2021-2025)
12.4 Plant Sources Anti Cancer Agents Market Forecast by Application (2021-2025)
12.4.1 Global Plant Sources Anti Cancer Agents Sales Forecast by Application (2021-2025)
12.4.2 Global Plant Sources Anti Cancer Agents Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Plant Sources Anti Cancer Agents Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Plant Sources Anti Cancer Agents by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Plant Sources Anti Cancer Agents Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Phyton Basic Information, Manufacturing Base and Competitors
Table 8. Phyton Plant Sources Anti Cancer Agents Major Business
Table 9. Phyton Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 10. Phyton SWOT Analysis
Table 11. Phyton Plant Sources Anti Cancer Agents Product and Services
Table 12. Phyton Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Huiang biopharma Basic Information, Manufacturing Base and Competitors
Table 14. Huiang biopharma Plant Sources Anti Cancer Agents Major Business
Table 15. Huiang biopharma Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 16. Huiang biopharma SWOT Analysis
Table 17. Huiang biopharma Plant Sources Anti Cancer Agents Product and Services
Table 18. Huiang biopharma Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Samyang Basic Information, Manufacturing Base and Competitors
Table 20. Samyang Plant Sources Anti Cancer Agents Major Business
Table 21. Samyang Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 22. Samyang SWOT Analysis
Table 23. Samyang Plant Sources Anti Cancer Agents Product and Services
Table 24. Samyang Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 26. ScinoPharm Plant Sources Anti Cancer Agents Major Business
Table 27. ScinoPharm Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 28. ScinoPharm SWOT Analysis
Table 29. ScinoPharm Plant Sources Anti Cancer Agents Product and Services
Table 30. ScinoPharm Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Fresenius-kabi Basic Information, Manufacturing Base and Competitors
Table 32. Fresenius-kabi Plant Sources Anti Cancer Agents Major Business
Table 33. Fresenius-kabi Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 34. Fresenius-kabi SWOT Analysis
Table 35. Fresenius-kabi Plant Sources Anti Cancer Agents Product and Services
Table 36. Fresenius-kabi Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novasep Basic Information, Manufacturing Base and Competitors
Table 38. Novasep Plant Sources Anti Cancer Agents Major Business
Table 39. Novasep Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 40. Novasep SWOT Analysis
Table 41. Novasep Plant Sources Anti Cancer Agents Product and Services
Table 42. Novasep Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Yunnan Hande Basic Information, Manufacturing Base and Competitors
Table 44. Yunnan Hande Plant Sources Anti Cancer Agents Major Business
Table 45. Yunnan Hande Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 46. Yunnan Hande SWOT Analysis
Table 47. Yunnan Hande Plant Sources Anti Cancer Agents Product and Services
Table 48. Yunnan Hande Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. TAPI (Teva) Basic Information, Manufacturing Base and Competitors
Table 50. TAPI (Teva) Plant Sources Anti Cancer Agents Major Business
Table 51. TAPI (Teva) Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 52. TAPI (Teva) SWOT Analysis
Table 53. TAPI (Teva) Plant Sources Anti Cancer Agents Product and Services
Table 54. TAPI (Teva) Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Polymed Basic Information, Manufacturing Base and Competitors
Table 56. Polymed Plant Sources Anti Cancer Agents Major Business
Table 57. Polymed Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 58. Polymed SWOT Analysis
Table 59. Polymed Plant Sources Anti Cancer Agents Product and Services
Table 60. Polymed Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Southpharma Basic Information, Manufacturing Base and Competitors
Table 62. Southpharma Plant Sources Anti Cancer Agents Major Business
Table 63. Southpharma Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 64. Southpharma SWOT Analysis
Table 65. Southpharma Plant Sources Anti Cancer Agents Product and Services
Table 66. Southpharma Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Actiza Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Major Business
Table 69. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 70. Actiza Pharmaceutical SWOT Analysis
Table 71. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product and Services
Table 72. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Cipla Basic Information, Manufacturing Base and Competitors
Table 74. Cipla Plant Sources Anti Cancer Agents Major Business
Table 75. Cipla Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 76. Cipla SWOT Analysis
Table 77. Cipla Plant Sources Anti Cancer Agents Product and Services
Table 78. Cipla Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Hainan Yew Pharm Basic Information, Manufacturing Base and Competitors
Table 80. Hainan Yew Pharm Plant Sources Anti Cancer Agents Major Business
Table 81. Hainan Yew Pharm Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 82. Hainan Yew Pharm SWOT Analysis
Table 83. Hainan Yew Pharm Plant Sources Anti Cancer Agents Product and Services
Table 84. Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Getwell Basic Information, Manufacturing Base and Competitors
Table 86. Getwell Plant Sources Anti Cancer Agents Major Business
Table 87. Getwell Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 88. Getwell SWOT Analysis
Table 89. Getwell Plant Sources Anti Cancer Agents Product and Services
Table 90. Getwell Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Pfizer Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer Plant Sources Anti Cancer Agents Major Business
Table 93. Pfizer Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 94. Pfizer SWOT Analysis
Table 95. Pfizer Plant Sources Anti Cancer Agents Product and Services
Table 96. Pfizer Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Jiangsu Yew Biotechnology Basic Information, Manufacturing Base and Competitors
Table 98. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Major Business
Table 99. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 100. Jiangsu Yew Biotechnology SWOT Analysis
Table 101. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product and Services
Table 102. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Salius Basic Information, Manufacturing Base and Competitors
Table 104. Salius Plant Sources Anti Cancer Agents Major Business
Table 105. Salius Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 106. Salius SWOT Analysis
Table 107. Salius Plant Sources Anti Cancer Agents Product and Services
Table 108. Salius Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Taj Pharma Plant Sources Anti Cancer Agents Type and Application
Table 110. Taj Pharma Plant Sources Anti Cancer Agents Major Business
Table 111. Taj Pharma Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 112. Taj Pharma SWOT Analysis
Table 113. Taj Pharma Plant Sources Anti Cancer Agents Product and Services
Table 114. Taj Pharma Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. West-Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Major Business
Table 117. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Total Revenue (USD Million) (2017-2018)
Table 118. West-Ward Pharmaceuticals SWOT Analysis
Table 119. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product and Services
Table 120. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Global Plant Sources Anti Cancer Agents Sales by Manufacturer (2018-2019) (MT)
Table 122. Global Plant Sources Anti Cancer Agents Revenue by Manufacturer (2018-2019) (USD Million)
Table 123. Global Plant Sources Anti Cancer Agents Sales by Regions (2015-2020) (MT)
Table 124. Global Plant Sources Anti Cancer Agents Sales Market Share by Regions (2015-2020)
Table 125. Global Plant Sources Anti Cancer Agents Revenue by Regions (2015-2020) (USD Million)
Table 126. North America Plant Sources Anti Cancer Agents Sales by Countries (2015-2020) (MT)
Table 127. North America Plant Sources Anti Cancer Agents Sales Market Share by Countries (2015-2020)
Table 128. North America Plant Sources Anti Cancer Agents Revenue by Countries (2015-2020) (USD Million)
Table 129. North America Plant Sources Anti Cancer Agents Revenue Market Share by Countries (2015-2020)
Table 130. Europe Plant Sources Anti Cancer Agents Sales by Countries (2015-2020) (MT)
Table 131. Europe Plant Sources Anti Cancer Agents Sales Market Share by Countries (2015-2020)
Table 132. Europe Plant Sources Anti Cancer Agents Revenue by Countries (2015-2020) (USD Million)
Table 133. Asia-Pacific Plant Sources Anti Cancer Agents Sales by Regions (2015-2020) (MT)
Table 134. Asia-Pacific Plant Sources Anti Cancer Agents Sales Market Share by Regions (2015-2020)
Table 135. Asia-Pacific Plant Sources Anti Cancer Agents Revenue by Regions (2015-2020) (USD Million)
Table 136. South America Plant Sources Anti Cancer Agents Sales by Countries (2015-2020) (MT)
Table 137. South America Plant Sources Anti Cancer Agents Sales Market Share by Countries (2015-2020)
Table 138. South America Plant Sources Anti Cancer Agents Revenue by Countries (2015-2020) (USD Million)
Table 139. South America Plant Sources Anti Cancer Agents Revenue Market Share by Countries (2015-2020)
Table 140. Middle East & Africa Plant Sources Anti Cancer Agents Sales by Countries (2015-2020) (MT)
Table 141. Middle East & Africa Plant Sources Anti Cancer Agents Sales Market Share by Countries (2015-2020)
Table 142. Middle East & Africa Plant Sources Anti Cancer Agents Revenue by Countries (2015-2020) (USD Million)
Table 143. Middle East & Africa Plant Sources Anti Cancer Agents Revenue Market Share by Countries (2015-2020)
Table 144. Global Plant Sources Anti Cancer Agents Sales by Type (2015-2020) (MT)
Table 145. Global Plant Sources Anti Cancer Agents Sales Share by Type (2015-2020)
Table 146. Global Plant Sources Anti Cancer Agents Revenue by Type (2015-2020) (USD Million)
Table 147. Global Plant Sources Anti Cancer Agents Revenue Share by Type (2015-2020)
Table 148. Global Plant Sources Anti Cancer Agents Sales by Application (2015-2020) (MT)
Table 149. Global Plant Sources Anti Cancer Agents Sales Share by Application (2015-2020)
Table 150. Global Plant Sources Anti Cancer Agents Sales Forecast by Regions (2021-2025) (MT)
Table 151. Global Plant Sources Anti Cancer Agents Market Share Forecast by Regions (2021-2025)
Table 152. Global Plant Sources Anti Cancer Agents Sales Forecast by Type (2021-2025) (MT)
Table 153. Global Plant Sources Anti Cancer Agents Market Share Forecast by Type (2021-2025)
Table 154. Global Plant Sources Anti Cancer Agents Sales Forecast by Application (2021-2025)
Table 155. Global Plant Sources Anti Cancer Agents Market Share Forecast by Application (2021-2025)
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Plant Sources Anti Cancer Agents Picture
Figure 2. Global Sales Market Share of Plant Sources Anti Cancer Agents by Type in 2019
Figure 3. Paclitaxel Picture
Figure 4. Vinorelbine Picture
Figure 5. Irinotecan Picture
Figure 6. Hydroxycamptothecin Picture
Figure 7. Docetaxel Picture
Figure 8. Other Picture
Figure 9. Plant Sources Anti Cancer Agents Sales Market Share by Application in 2018
Figure 10. Ovarian Cancer Picture
Figure 11. Cervical Cancer Picture
Figure 12. Breast Cancer Picture
Figure 13. Other Picture
Figure 14. Global Plant Sources Anti Cancer Agents Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Plant Sources Anti Cancer Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Plant Sources Anti Cancer Agents Sales Market Share by Manufacturer in 2019
Figure 35. Global Plant Sources Anti Cancer Agents Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Plant Sources Anti Cancer Agents Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Plant Sources Anti Cancer Agents Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 40. Global Plant Sources Anti Cancer Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Plant Sources Anti Cancer Agents Revenue Market Share by Regions (2015-2020)
Figure 42. Global Plant Sources Anti Cancer Agents Revenue Market Share by Regions in 2018
Figure 43. North America Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
Figure 44. Europe Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
Figure 46. South America Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020)
Figure 48. North America Plant Sources Anti Cancer Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Plant Sources Anti Cancer Agents Sales Market Share by Countries (2015-2020)
Figure 50. North America Plant Sources Anti Cancer Agents Sales Market Share by Countries in 2018
Figure 51. North America Plant Sources Anti Cancer Agents Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Plant Sources Anti Cancer Agents Revenue Market Share by Countries in 2018
Figure 53. United States Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 54. Canada Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 55. Mexico Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 56. Europe Plant Sources Anti Cancer Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Plant Sources Anti Cancer Agents Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Plant Sources Anti Cancer Agents Revenue Market Share by Countries in 2019
Figure 59. Germany Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 60. UK Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 61. France Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 62. Russia Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 63. Italy Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 64. Asia-Pacific Plant Sources Anti Cancer Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Plant Sources Anti Cancer Agents Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Plant Sources Anti Cancer Agents Revenue Market Share by Regions 2019
Figure 67. China Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 68. Japan Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 69. Korea Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 70. India Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 71. Southeast Asia Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 72. South America Plant Sources Anti Cancer Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Plant Sources Anti Cancer Agents Sales Market Share by Countries in 2019
Figure 74. South America Plant Sources Anti Cancer Agents Revenue Market Share by Countries in 2019
Figure 75. Brazil Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 76. Argentina Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 77. Middle East and Africa Plant Sources Anti Cancer Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Plant Sources Anti Cancer Agents Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Plant Sources Anti Cancer Agents Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Plant Sources Anti Cancer Agents Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 82. Egypt Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 83. Turkey Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 84. South Africa Plant Sources Anti Cancer Agents Sales and Growth Rate (2015-2020) (MT)
Figure 85. Global Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2025) (MT)
Figure 86. Global Plant Sources Anti Cancer Agents Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Plant Sources Anti Cancer Agents Market Forecast (2021-2025) (MT)
Figure 88. Europe Sales Plant Sources Anti Cancer Agents Market Forecast (2021-2025) (MT)
Figure 89. Asia-Pacific Sales Plant Sources Anti Cancer Agents Market Forecast (2021-2025) (MT)
Figure 90. South America Sales Plant Sources Anti Cancer Agents Market Forecast (2021-2025) (MT)
Figure 91. Middle East & Africa Sales Plant Sources Anti Cancer Agents Market Forecast (2021-2025) (MT)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
抗腫瘍剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti - Neoplastic Agents market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti - Neoplastic Ag…- 子宮頸がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Cervical Cancer Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 子宮頸癌の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cervical Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cervical Cancer market report…
- アスファルト剥離防止剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Asphalt Anti-Stripping Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- アスファルト剥離防止剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Asphalt Anti-Stripping Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…